# Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)

> **NCT05394623** · — · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 5000 (estimated)

## Conditions studied

- Hepatitis D
- Hepatitis B
- Antibodies; Anti-D
- RNA Virus Infections

## Interventions

- **DIAGNOSTIC_TEST:** HDV-Ab (IgG), HDV-RNA, RNA genotype

## Key facts

- **NCT ID:** NCT05394623
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-11-01
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2022-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05394623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05394623, "Prevalence and Burden of Hepatitis D Virus Infection in China Through Preoperative Examination Test (Predict Study)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05394623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*